Three Leaf Ventures Leads Cohero Health’s $9M Series A Funding, Accelerating Commercial Access to BreatheSmart – the Leading Respiratory Disease Management Platform

Three Leaf Ventures’ Investment Continues Transformation of Healthcare Through Technological Innovation   DENVER – Nov. 2, 2016 — Three Leaf Ventures, the Denver-based venture-stage fund fueling healthcaretechnology innovation, has led Cohero Health’s $9 million Series A financingto accelerate commercial access to BreatheSmart, the leading respiratory disease management platform. Three Leaf Ventures, a managed affiliate of […]

Impact Pediatric Health Startup Pitch Competition Announces Winner, Cohero Health

Austin, Texas, March 14, 2016 – Impact Pediatric Health just named Cohero Health as winner of its SXSW Interactive pediatric healthcare innovation pitch competition. Cohero Health is focused on improving respiratory care for kids, especially those with asthma and competed against 9 other startup companies today. Steve Case, co-founder of AOL and Chairman and CEO […]

Cohero Health Secures $2M Seed Investment

Creator of innovative respiratory disease management platform closes seed round, led by Blue Cross Blue Shield of Massachusetts’ Zaffre Investments. NEW YORK, NY December 15, 2015 Cohero Health, a digital health company focused on developing connected health tools and technologies to empower respiratory patients and improve care through smart mobile devices, has announced that they closed a seed investment round […]

Human Longevity Acquires Cypher Genomics

Nov 30, 2015 NEW YORK (GenomeWeb) – Human Longevity said today that it has acquired genome informatics firm Cypher Genomics for an undisclosed amount. San Diego-based Cypher Genomics has been offering human genome interpretation software. The company’s 14 employees will join Human Longevity, including CEO and cofounder Ashley Van Zeeland, who is now heading Human […]

Invitae Goes Public with $101.6M Offering

NEW YORK (GenomeWeb) – Invitae has launched its initial public offering at $16 per share. The San Francisco-based molecular diagnostics firm offered 6,350,000 shares of its common stock, bringing in gross proceeds of $101.6 million. It also has granted the underwriters a 30-day option to purchase up to an additional 952,500 shares. The offering price […]

Invitae Corporation files registration statement for proposed initial public offering

SAN FRANCISCO —January 9, 2015—Invitae Corporation announced today that it has filed a registration statement on Form S‐1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the offering have not yet […]

Invitae announces reimbursement coverage decision by Blue Shield of California and acceptance as a Medicare provider

SAN FRANCISCO, December 3, 2014 – Invitae Corporation, a genetic information company, announced that its testing services are eligible for coverage by two additional payors, Blue Shield of California and the Centers for Medicare and Medicaid Services (CMS). “Securing reimbursement is an important step towards realizing our mission to make genetic testing affordable and accessible […]